Michael Sadhra - Net Worth and Insider Trading
Michael Sadhra Net Worth
The estimated net worth of Michael Sadhra is at least $194 dollars as of 2024-09-21. Michael Sadhra is the Senior Officer of Algernon Pharmaceuticals Inc and owns about 2,280 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) stock worth over $194. Details can be seen in Michael Sadhra's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Sadhra has not made any transactions after 2021-11-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Sadhra
Michael Sadhra Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Sadhra owns 1 companies in total, including Algernon Pharmaceuticals Inc (XCNQ:AGN) .
Click here to see the complete history of Michael Sadhra’s form 4 insider trades.
Insider Ownership Summary of Michael Sadhra
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XCNQ:AGN | Algernon Pharmaceuticals Inc | 2021-11-19 | Senior Officer |
Michael Sadhra Latest Holdings Summary
Michael Sadhra currently owns a total of 1 stock. Michael Sadhra owns 2,280 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) as of November 19, 2021, with a value of $194.
Latest Holdings of Michael Sadhra
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XCNQ:AGN | Algernon Pharmaceuticals Inc | 2021-11-19 | 2,280 | 0.09 | 194 |
Holding Weightings of Michael Sadhra
Michael Sadhra Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Sadhra has made a total of 12 transactions in Algernon Pharmaceuticals Inc (XCNQ:AGN) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Algernon Pharmaceuticals Inc is the sale of 11,520 shares on November 19, 2021, which brought Michael Sadhra around $286,540.
Insider Trading History of Michael Sadhra
- 1
Michael Sadhra Trading Performance
Michael Sadhra Ownership Network
Michael Sadhra Owned Company Details
What does Algernon Pharmaceuticals Inc do?
Who are the key executives at Algernon Pharmaceuticals Inc?
Michael Sadhra is the Senior Officer of Algernon Pharmaceuticals Inc. Other key executives at Algernon Pharmaceuticals Inc include Director & Senior Officer Christopher Moreau , Senior Officer Christopher Scott Bryan , and Senior Officer James Kinley .
Algernon Pharmaceuticals Inc (XCNQ:AGN) Insider Trades Summary
Over the past 18 months, Michael Sadhra made no insider transaction in Algernon Pharmaceuticals Inc (XCNQ:AGN). Other recent insider transactions involving Algernon Pharmaceuticals Inc (XCNQ:AGN) include a net purchase of 60,500 shares made by Christopher Scott Bryan , a net purchase of 52,500 shares made by Christopher Moreau , and a net purchase of 12,500 shares made by James Kinley .
In summary, during the past 3 months, insiders sold 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) were sold and 125,500 shares were bought by its insiders, resulting in a net purchase of 125,500 shares.
Algernon Pharmaceuticals Inc (XCNQ:AGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Algernon Pharmaceuticals Inc Insider Transactions
Michael Sadhra Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Sadhra. Currently GuruFocus does not have mailing address information for Michael Sadhra.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
